Persistence of multidrug-resistant Staphylococcus haemolyticus in an animal veterinary teaching hospital clinic

Maan Singh Sidhu1, Hanne Oppegaard, Tone Pahle Devor

  • 1Department of Food Safety and Infection Biology, The Norwegian School of Veterinary Science, Oslo, Norway. maan.singh.sidhu@animalia.com

Microbial Drug Resistance (Larchmont, N.Y.)
|January 11, 2008
PubMed

Insights

Multidrug-resistant Staphylococcus haemolyticus, a significant nosocomial pathogen, was found persisting in an animal clinic environment over three years. This highlights the mobility of resistance genes and the evolution of bacterial resistance in veterinary settings.

Area of Science:

  • Veterinary Microbiology
  • Antimicrobial Resistance
  • Molecular Epidemiology

Background:

  • Coagulase-negative staphylococci (CNS) are increasingly recognized as nosocomial pathogens, exhibiting resistance to antibiotics and disinfectants.
  • Multidrug-resistant CNS are prevalent in human hospitals, but their occurrence and persistence in veterinary settings remain understudied.
  • Understanding the environmental reservoirs and transmission dynamics of resistant bacteria in animal clinics is crucial for public health.

Purpose of the Study:

  • To investigate the presence and persistence of multidrug-resistant CNS in the environment of a small animal clinic.
  • To characterize the genetic basis and epidemiological relatedness of multidrug-resistant Staphylococcus haemolyticus isolates found in the clinic.

Main Methods:

  • Environmental sampling within a small animal clinic over a three-year period.
  • Isolation and identification of bacterial species, focusing on Staphylococcus haemolyticus.
  • Molecular techniques including pulsed-field electrophoresis, multilocus enzyme typing, and genotypic characterization of resistance genes (e.g., mecA, blaZ, qacA/B, tetK, ermB, cat, aacA-aphD).
  • Plasmid analysis and investigation of gene integration mechanisms (e.g., IS257).

Main Results:

  • Multidrug-resistant Staphylococcus haemolyticus was isolated from cage floors and a cat's wound infection, indicating persistence over three years.
  • All isolates belonged to a single epidemiological clone and harbored a chromosomal mecA gene and a plasmid with blaZ and qacA/B.
  • Multiple small plasmids (<5 kb) conferred resistance to tetracycline (tetK), macrolides (ermB), and chloramphenicol (cat); one isolate also had gentamicin resistance (aacA-aphD).
  • IS257-mediated integration of the tetK plasmid into the chromosome was observed in a macrolide- and chloramphenicol-susceptible isolate, demonstrating gene mobility.

Conclusions:

  • Multidrug-resistant Staphylococcus haemolyticus can persist in animal clinic environments, posing a potential risk.
  • The study demonstrates significant intracellular mobility of bacterial resistance genes, facilitated by insertion sequences like IS257.
  • Findings underscore the importance of monitoring antimicrobial resistance in veterinary settings and understanding the evolution of resistance determinants.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...